DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
Tapson VF, Torres F, Kermeen F et al.
Oral treprostinil for the treatment of pulmonary arterial hypertension in patients on background endothelin receptor antagonist and/or phosphodiesterase type 5 inhibitor therapy (the FREEDOM-C study): a randomized controlled trial.
Chest 2012;
142: 1383-1390
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.